Literature DB >> 16831864

Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols.

Bao-Liang Song1, Russell A DeBose-Boyd.   

Abstract

Sterol-regulated ubiquitination marks 3-hydroxy-3-methylglutaryl coenzyme A reductase, a rate-determining enzyme in cholesterol synthesis, for endoplasmic reticulum (ER)-associated degradation by 26 S proteasomes. This degradation, which results from sterol-induced binding of reductase to ER membrane proteins called Insigs, contributes to the complex, multivalent feedback regulation of the enzyme. Degradation of HMG-CoA reductase is also stimulated by various forms of vitamin E, a generic term for alpha-, beta-, delta-, and gamma-tocopherols and tocotrienols, which are primarily recognized for their potent antioxidant activity. Here, we show that delta-tocotrienol stimulates ubiquitination and degradation of reductase and blocks processing of sterol regulatory element-binding proteins (SREBPs), another sterol-mediated action of Insigs. The gamma-tocotrienol analog is more selective in enhancing reductase ubiquitination and degradation than blocking SREBP processing. Other forms of vitamin E neither accelerate reductase degradation nor block SREBP processing. In vitro assays indicate that gamma- and delta-tocotrienol trigger reductase ubiquitination directly and do not require further metabolism for activity. Taken together, these results provide a biochemical mechanism for the hypocholesterolemic effects of vitamin E that have been observed in animals and humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831864     DOI: 10.1074/jbc.M605575200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Vivek R Yadav; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

Review 2.  Utilization of Vitamin E Analogs to Protect Normal Tissues While Enhancing Antitumor Effects.

Authors:  Nukhet Aykin-Burns; Rupak Pathak; Marjan Boerma; Thomas Kim; Martin Hauer-Jensen
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

3.  Mechanisms underlying the radioprotective properties of γ-tocotrienol: comparative gene expression profiling in tocol-treated endothelial cells.

Authors:  Maaike Berbée; Qiang Fu; Marjan Boerma; K Sree Kumar; David S Loose; Martin Hauer-Jensen
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

4.  Tocotrienol attenuates triglyceride accumulation in HepG2 cells and F344 rats.

Authors:  Gregor Carpentero Burdeos; Kiyotaka Nakagawa; Fumiko Kimura; Teruo Miyazawa
Journal:  Lipids       Date:  2012-02-26       Impact factor: 1.880

Review 5.  Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy.

Authors:  Qing Jiang
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

Review 6.  Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols.

Authors:  Chung S Yang; Philip Luo; Zishuo Zeng; Hong Wang; Mokenge Malafa; Nanjoo Suh
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

7.  γ-Tocotrienol Inhibits TGF-β1-Induced Contractile Phenotype Expression of Human Airway Smooth Muscle Cells.

Authors:  Takehito Fukushima; Akira Yamasaki; Tomoya Harada; Hiroki Chikumi; Masanari Watanabe; Ryota Okazaki; Miki Takata; Yasuyuki Hasegawa; Jun Kurai; Masaaki Yanai; Akihiro Yamamoto; Yuriko Sueda; Andrew J Halayko; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

Review 8.  New compounds able to control hepatic cholesterol metabolism: Is it possible to avoid statin treatment in aged people?

Authors:  Laura Trapani; Marco Segatto; Valentina Pallottini
Journal:  World J Hepatol       Date:  2013-12-27

9.  Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.

Authors:  Zhihong Yang; Hang Xiao; Huanyu Jin; Phillip T Koo; Dorothea J Tsang; Chung S Yang
Journal:  Int J Cancer       Date:  2010-02-15       Impact factor: 7.396

10.  Supplementation with tocotrienol-rich fraction alters the plasma levels of Apolipoprotein A-I precursor, Apolipoprotein E precursor, and C-reactive protein precursor from young and old individuals.

Authors:  Eng Chee Heng; Saiful Anuar Karsani; Mariati Abdul Rahman; Noor Aini Abdul Hamid; Zalina Hamid; Wan Zurinah Wan Ngah
Journal:  Eur J Nutr       Date:  2013-01-04       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.